Increased Serum Levels of Vascular Endothelial Growth Factor in Patients with Renal Cell Carcinoma-Reference-Cited by-同舟云学术

Increased Serum Levels of Vascular Endothelial Growth Factor in Patients with Renal Cell Carcinoma

Published:1999-08 Issue:8 Volume:90 Page:874-879
ISSN:0910-5050
Container-title:Japanese Journal of Cancer Research
language:en
Short-container-title:

Author:

Sato Kazunari,Tsuchiya Norihiko,Sasaki Ryusei,Shimoda Naotake,Satoh Shigeru,Ogawa Osamu,Kato Tetsuro

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1349-7006.1999.tb00829.x/fullpdf

Reference31 articles.

1. Tumor angiogenesis: therapeutic implications;Folkman;N. Engl. J. Med.,1971

2. Prognostic significance of microvessel count in low stage renal cell carcinoma;Yoshino;Int. J. Urol.,1995

3. Microvessel count and cerebrospinal fluid basic fibroblast growth factor in children with brain tumors;Li;Lancet,1994

4. Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis and proliferation;Takahashi;Cancer Res.,1995

5. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma;Weidner;N. Engl. J. Med.,1991

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phase IB/II Trial of Lenvatinib Plus Pembrolizumab in Patients With Advanced Renal Cell Carcinoma, Endometrial Cancer, and Other Selected Advanced Solid Tumors;Journal of Clinical Oncology;2020-04-10

2. Clinical Outcomes by Nephrectomy Status In METEOR, A Randomized Phase 3 Trial of Cabozantinib Versus Everolimus in Patients with Advanced Renal Cell Carcinoma;Kidney Cancer;2020-03-30

3. Surgical Management of Advanced Kidney Cancer: The Role of Cytoreductive Nephrectomy and Lymphadenectomy;Journal of Clinical Oncology;2018-12-20

4. Phase 2 Study of Bevacizumab and Temsirolimus After VEGFR TKI in Metastatic Renal Cell Carcinoma;Clinical Genitourinary Cancer;2016-08

5. Infiltrating T cells promote renal cell carcinoma (RCC) progressionviaaltering the estrogen receptor β-DAB2IP signals;Oncotarget;2015-11-17